Leadiant Biosciences, Inc.
5 clinical trials · Sponsor
◉ Watch Leadiant Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX) (NCT06260748) | Leadiant Biosciences, Inc. | 2024-05-27 |
Track Leadiant Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.